pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
RAP-103
Dementia Associated With Alzheimer's Disease
Creative Bio-Peptides Inc
0
catalysts
Phase 2
RAP-219
Bipolar I Disorder
$RAPP
Rapport Therapeutics, Inc.
0
catalysts
Phase 2
RAPA-201
Refractory Multiple Myeloma
Rapa Therapeutics LLC
0
catalysts
Phase 2
RB-601
Head And Neck Cancer
← prev
page 147 of 271
next →
131
Pain
89
Neurology
1
Radiance Biopharma Inc
0
catalysts
Preclinical
RBIO-101
Reflection Biotechnologies Ltd
0
catalysts
Phase 1
RBM-001
Coronavirus Disease 2019 (COVID-19)
Rock Biomedical Inc
0
catalysts
Phase 1
RCI-001
Keratoconjunctivitis Sicca (Dry Eye)
Rudacure Co Ltd
0
catalysts
Phase 1
RCT-1100
Primary Ciliary Dyskinesia
Recode Therapeutics Inc
0
catalysts
Phase 2
RCT-2100
Cystic Fibrosis
Recode Therapeutics Inc
0
catalysts
Phase 2
RD-1302
T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Imviva Biotech
0
catalysts
Preclinical
RDX-10531
Unspecified
$ARDX
ARDELYX, INC.
0
catalysts
REBLOZYL
REBLOZYL (LUSPATERCEPT-AAMT)
Celgene Corp
0
catalysts
Phase 2
REC-1245
Lymphoma
$RXRX
RECURSION PHARMACEUTICALS, INC.
0
catalysts
Phase 1
REC-4539
Gastric Cancer
$RXRX
RECURSION PHARMACEUTICALS, INC.
0
catalysts
Phase 2
REC-4881
Familial Adenomatous Polyposis
Dual specificity mitogen-activated protein kinase kinase 1
Dual specificity mitogen-activated protein kinase kinase 2
$RXRX
RECURSION PHARMACEUTICALS, INC.
0
catalysts
RECARBRIO
RECARBRIO (CILASTATIN SODIUM)
1 INDICATIONS AND USAGE RECARBRIO is a combination of imipenem, a penem antib…
Dipeptidase 1
$MRK
Merck & Co., Inc.
0
catalysts
Preclinical
RECCE-529
Coronavirus Disease 2019 (COVID-19)
Recce Pharmaceuticals Ltd
0
catalysts
RECLAST
RECLAST (ZOLEDRONIC ACID)
Sandoz Inc
0
catalysts
REDEMPLO
REDEMPLO (PLOZASIRAN SODIUM)
1 INDICATIONS AND USAGE REDEMPLO is indicated as an adjunct to diet to reduce…
$ARWR
ARROWHEAD PHARMACEUTICALS, INC.
0
catalysts
REGADENOSON
REGADENOSON (REGADENOSON)
APOTEX
0
catalysts
Marketed
REGLAN
REGLAN (METOCLOPRAMIDE HYDROCHLORIDE)
Diabetic Gastroparesis
$ANIP
ANI PHARMACEUTICALS INC
0
catalysts
Phase 2
REGV-131
Hemophilia B (Factor IX Deficiency)
$REGN
REGENERON PHARMACEUTICALS, INC.
0
catalysts
Phase 2
REM-422
Adenoid Cystic Carcinoma (ACC)
Remix Therapeutics Inc
0
catalysts
RENACIDIN
RENACIDIN (CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE)
UNITED GUARDIAN
0
catalysts
RENFLEXIS
RENFLEXIS (INFLIXIMAB-ABDA)
Samsung Bioepis Co Ltd
0
catalysts
Preclinical
REP-0003
Homozygous Familial Hypercholesterolemia (HoFH)
Repair Biotechnologies Inc
0
catalysts
Phase 3
RESCAP
Acute Renal Failure (ARF) (Acute Kidney Injury)
Alloksys Life Sciences BV
0
catalysts
RETEVMO
RETEVMO (SELPERCATINIB)
1 INDICATIONS AND USAGE RETEVMO ® is a kinase inhibitor indicated for the tre…
Coiled-coil domain-containing protein 6/Tyrosine-protein kinase receptor RET
Proto-oncogene tyrosine-protein kinase receptor Ret
$LLY
ELI LILLY & Co
0
catalysts
Preclinical
REV-0100
Juvenile Macular Degeneration (Stargardt Disease)
ReVision Therapeutics Inc
0
catalysts
Phase 2
REVTX-300
Chronic Kidney Disease (Chronic Renal Failure)
$REVB
REVELATION BIOSCIENCES, INC.
0
catalysts
